71 related articles for article (PubMed ID: 2741142)
21. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
22. Nonproliferative epithelial alteration and expression of estrogen receptor and Ki67 in the contralateral breast of women treated with tamoxifen for breast cancer.
de Souza Sales JF; Cabello C; Alvarenga M; Torresan RZ; Duarte GM
Breast; 2007 Apr; 16(2):197-203. PubMed ID: 17178225
[TBL] [Abstract][Full Text] [Related]
23. [Clinical implications of telomerase activity in breast cancer fine-needle aspirates].
Jin S; Zhang W; Teng M
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):132-4. PubMed ID: 11776640
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor determination in fine needle aspirates of the breast. Correlation with histologic grade and comparison with biochemical analysis.
Lozowski MS; Mishriki Y; Chao S; Grimson R; Pai P; Harris MA; Lundy J
Acta Cytol; 1987; 31(5):557-62. PubMed ID: 3314302
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of estrogen receptors in cells obtained by fine needle aspiration from human mammary carcinomas.
Azavedo E; Baral E; Skoog L
Anticancer Res; 1986; 6(2):263-6. PubMed ID: 3518595
[TBL] [Abstract][Full Text] [Related]
27. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
29. Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates.
Masood S
Am J Clin Pathol; 1991 Jan; 95(1):35-40. PubMed ID: 1987750
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
[TBL] [Abstract][Full Text] [Related]
31. Breast carcinomas with immunocytochemical detection of aromatase in fine-needle aspirates: report of three cases.
Tsunoda Y; Shimizu Y; Tsunoda A; Kamiya K; Kusano M; Takimoto M
Hum Pathol; 2001 Mar; 32(3):348-51. PubMed ID: 11274648
[TBL] [Abstract][Full Text] [Related]
32. A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles.
Lu D; Masood S; Khalbuss WE; Bui M
Cancer; 2002 Oct; 96(5):294-300. PubMed ID: 12378597
[TBL] [Abstract][Full Text] [Related]
33. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma.
Sentani K; Tashiro T; Oue N; Yasui W
APMIS; 2007 Dec; 115(12):1422-5. PubMed ID: 18184414
[No Abstract] [Full Text] [Related]
34. Fluoresceinated estrone binding by human and mouse breast cancer cells.
Fisher B; Gunduz N; Zheng S; Saffer EA
Cancer Res; 1982 Feb; 42(2):540-9. PubMed ID: 7055802
[No Abstract] [Full Text] [Related]
35. Comparison of core needle biopsy and surgical specimens in malignant breast lesions regarding histological features and hormone receptor expression.
Abdsaleh S; Wärnberg F; Azavedo E; Lindgren PG; Amini RM
Histopathology; 2008 May; 52(6):773-5. PubMed ID: 18393972
[No Abstract] [Full Text] [Related]
36. Primary osteogenic sarcoma and osteogenic metaplastic carcinoma of the breast. Immunocytochemical identification in fine needle aspirates.
Pettinato G; Manivel JC; Petrella G; De Chiara A; Calí A
Acta Cytol; 1989; 33(5):620-6. PubMed ID: 2781963
[TBL] [Abstract][Full Text] [Related]
37. [Drill biopsy and puncture biopsy for the determination of hormone receptors].
Magdelenat H
Pathol Biol (Paris); 1983 Nov; 31(9):755-60. PubMed ID: 6361673
[TBL] [Abstract][Full Text] [Related]
38. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME
Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137
[TBL] [Abstract][Full Text] [Related]
39. Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls.
Moriki T; Takahashi T; Ueta S; Mitani M; Ichien M
Diagn Cytopathol; 2004 Apr; 30(4):251-6. PubMed ID: 15048960
[TBL] [Abstract][Full Text] [Related]
40. Progesterone-receptor assay in fine needle aspirates of breast tumors.
Merle S; Zajdela A; Magdelenat H
Acta Cytol; 1985; 29(3):496-8. PubMed ID: 3859152
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
